TY - JOUR
T1 - Dietary interventions improve diabetic kidney disease, but not peripheral neuropathy, in a db/db mouse model of type 2 diabetes
AU - Eid, Stephanie A.
AU - O'Brien, Phillipe D.
AU - Kretzler, Katharina H.
AU - Jang, Dae Gyu
AU - Mendelson, Faye E.
AU - Hayes, John M.
AU - Carter, Andrew
AU - Zhang, Hongyu
AU - Pennathur, Subramaniam
AU - Brosius, Frank C.
AU - Koubek, Emily J.
AU - Feldman, Eva L.
N1 - Funding Information:
The authors acknowledge the technical expertise of Crystal Pacut at the University of Michigan in performing ELISAs. Funding support was provided by the National Institute of Health (NIH, P30DK020572 to S.A.E. and R01DK130913, R24DK082841 to E.L.F.), the Novo Nordisk Foundation (NNF14OC0011633), the Juvenile Diabetes Research Foundation (5COE‐2019‐861‐S‐B), the Sinai Medical Staff Foundation, the Nathan and Rose Milstein Emerging Scholar Fund (to S.A.E.), the Robert and Katherine Jacobs Environmental Health Initiative, the Tauber Family Student Internship Program, the A. Alfred Taubman Medical Research Institute, and the NeuroNetwork for Emerging Therapies (to E.L.F. and S.A.E.). Research reported in this study was also made possible by Core Services provided by the University of Michigan O'Brien Kidney Translational Core Center funded by the NIH (P30 DK081943 and P30 DK089503) and by the Mouse Metabolic Phenotyping Center (MMPC) supported by the National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) of the NIH under Award Numbers U2CDK110768 (Michigan MMPC) and U2CDK059630 (Cincinnati MMPC).
Publisher Copyright:
© 2023 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.
PY - 2023/8
Y1 - 2023/8
N2 - Patients with type 2 diabetes often develop the microvascular complications of diabetic kidney disease (DKD) and diabetic peripheral neuropathy (DPN), which decrease quality of life and increase mortality. Unfortunately, treatment options for DKD and DPN are limited. Lifestyle interventions, such as changes to diet, have been proposed as non-pharmacological treatment options for preventing or improving DKD and DPN. However, there are no reported studies simultaneously evaluating the therapeutic efficacy of varying dietary interventions in a type 2 diabetes mouse model of both DKD and DPN. Therefore, we compared the efficacy of a 12-week regimen of three dietary interventions, low carbohydrate, caloric restriction, and alternate day fasting, for preventing complications in a db/db type 2 diabetes mouse model by performing metabolic, DKD, and DPN phenotyping. All three dietary interventions promoted weight loss, ameliorated glycemic status, and improved DKD, but did not impact percent fat mass and DPN. Multiple regression analysis identified a negative correlation between fat mass and motor nerve conduction velocity. Collectively, our data indicate that these three dietary interventions improved weight and glycemic status and alleviated DKD but not DPN. Moreover, diets that decrease fat mass may be a promising non-pharmacological approach to improve DPN in type 2 diabetes given the negative correlation between fat mass and motor nerve conduction velocity.
AB - Patients with type 2 diabetes often develop the microvascular complications of diabetic kidney disease (DKD) and diabetic peripheral neuropathy (DPN), which decrease quality of life and increase mortality. Unfortunately, treatment options for DKD and DPN are limited. Lifestyle interventions, such as changes to diet, have been proposed as non-pharmacological treatment options for preventing or improving DKD and DPN. However, there are no reported studies simultaneously evaluating the therapeutic efficacy of varying dietary interventions in a type 2 diabetes mouse model of both DKD and DPN. Therefore, we compared the efficacy of a 12-week regimen of three dietary interventions, low carbohydrate, caloric restriction, and alternate day fasting, for preventing complications in a db/db type 2 diabetes mouse model by performing metabolic, DKD, and DPN phenotyping. All three dietary interventions promoted weight loss, ameliorated glycemic status, and improved DKD, but did not impact percent fat mass and DPN. Multiple regression analysis identified a negative correlation between fat mass and motor nerve conduction velocity. Collectively, our data indicate that these three dietary interventions improved weight and glycemic status and alleviated DKD but not DPN. Moreover, diets that decrease fat mass may be a promising non-pharmacological approach to improve DPN in type 2 diabetes given the negative correlation between fat mass and motor nerve conduction velocity.
KW - caloric restriction
KW - db/db mouse model
KW - diabetic kidney disease
KW - diabetic neuropathy
KW - intermittent fasting
KW - low-carbohydrate diet
KW - type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85165744654&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85165744654&partnerID=8YFLogxK
U2 - 10.1096/fj.202300354R
DO - 10.1096/fj.202300354R
M3 - Article
C2 - 37490006
AN - SCOPUS:85165744654
SN - 0892-6638
VL - 37
JO - FASEB Journal
JF - FASEB Journal
IS - 8
M1 - e23115
ER -